MedTrace Logo

Investigation of the Genetic and Environmental Determinants of MP Including Response to Supplementation

NCT01778231 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2019-08-14

No results posted yet for this study

Summary

This study aims to investigate genetic and environmental determinants of macular pigment (MP) and assess the effects of lutein and zeaxanthin-rich supplements on macular pigment levels.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Nutrof Total

Antioxidant and trace element supplement

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • Queen's University, Belfast

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2013-05-31
Completion
2013-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01778231 on ClinicalTrials.gov